UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000013552 |
|---|---|
| Receipt number | R000015666 |
| Scientific Title | A phase I/II clinical trial of carbon-ion therapy for patients with clinical stage I squamous cell carcinoma of the thoracic esophagus |
| Date of disclosure of the study information | 2014/03/31 |
| Last modified on | 2019/10/04 15:34:02 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A phase I/II clinical trial of carbon-ion therapy for patients with clinical stage I squamous cell carcinoma of the thoracic esophagus
Acronym
A phase I/II clinical trial of carbon-ion radiotherapy for stage I esophageal squamous cell carcinoma
Scientific Title
A phase I/II clinical trial of carbon-ion therapy for patients with clinical stage I squamous cell carcinoma of the thoracic esophagus
Scientific Title:Acronym
A phase I/II clinical trial of carbon-ion radiotherapy for stage I esophageal squamous cell carcinoma
Region
| Japan |
Condition
Condition
Esophageal cancer
Classification by specialty
| Gastroenterology | Gastrointestinal surgery | Radiology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the safety and therapeutic effect of carbon-ion radiotherapy for stage I thoracic esophageal cancer
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Confirmatory
Trial characteristics_2
Developmental phase
Phase I,II
Assessment
Primary outcomes
Acute adverse events
Response rate
Key secondary outcomes
Local control rate
Survival rate
Late adverse events
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Device,equipment | Maneuver |
Interventions/Control_1
Carbon-ion radiotherapy: in 12 fractions over 3 weeks.
The total radiation dose is escalated from the initial dose of 43.2 GyE.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| 80 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
1.Histologically proven squamous cell carcinoma of the thoracic esophagus
2.Clinical stage I (T1bN0M0) according to the Japanese classification of esophageal cancer (10th edition)
3.Measurable lesion
4.Age of 80 years or younger
5.Performance status between 0 and 2
6.Written informed consent
Key exclusion criteria
1.Ttumor size more than 8 cm
2.Intramural metastasis
3.Prior treatments for the esophageal lesion
4.Previous radiotherapy in the treatment area
5.Other active cancer
6.Active infection
7.Serious medical or psychological problems
Target sample size
20
Research contact person
Name of lead principal investigator
| 1st name | Shigeo |
| Middle name | |
| Last name | Yasuda |
Organization
National Institutes for Quantum and Radiological Science and Technology
Division name
QST Hospital
Zip code
263-8555
Address
4-9-1, Anagawa, Inage-ku, Chiba
TEL
043-206-3306
yasudash@qst.go.jp
Public contact
Name of contact person
| 1st name | Shigeo |
| Middle name | |
| Last name | Yasuda |
Organization
National Institutes for Quantum and Radiological Science and Technology
Division name
QST Hospital
Zip code
263-8555
Address
4-9-1, Anagawa, Inage-ku, Chiba
TEL
043-206-3306
Homepage URL
yasudash@qst.go.jp
Sponsor or person
Institute
National Institutes for Quantum and Radiological Science and Technology
National Institute of Radiological Sciences
Institute
Department
Personal name
Funding Source
Organization
National Institutes for Quantum and Radiological Science and Technology
National Institute of Radiological Sciences
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
the NIRS Ethics Committee on Human Clinical Research
Address
4-9-1, Anagawa, Inage-ku, Chiba
Tel
043-206-3193
genkoba@qst.go.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2014 | Year | 03 | Month | 31 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2008 | Year | 03 | Month | 07 | Day |
Date of IRB
Anticipated trial start date
| 2008 | Year | 04 | Month | 01 | Day |
Last follow-up date
| 2018 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2014 | Year | 03 | Month | 28 | Day |
Last modified on
| 2019 | Year | 10 | Month | 04 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015666
